Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin Genetics Files to Raise up to $75M

NEW YORK (GenomeWeb News) – Interleukin Genetics has filed a shelf registration with the US Securities and Exchange Commission seeking to sell up to $75 million worth of stock or debt instruments.

The firm said in its SEC registration that it may offer shares of common stock and preferred stock, debt securities, warrants, or rights or contracts for any of those securities, either individually or in units.

The Waltham, Mass.-based genetic testing company is developing gene-based prediction tests for tooth loss, osteoporosis, heart health, bone health, and risk tests for other conditions.

As of Sep. 30, Interleukin held $1.4 million in cash and cash equivalents.

Interleukin Genetics' stock closed down 5 percent at $.77 per share in Wednesday trade on the American Stock Exchange.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.